Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiake Xu

Showing results (321-330 of 401) with videos related to

Pageof 41
Sort By:
Frontiers in Pharmacology|March 18, 2022
Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced OsteolysisLinke Huang, Weiwei Chen, Linhua Wei, et al.
Biochemical Pharmacology|February 6, 2019
Dehydrocostus lactone (DHC) suppresses estrogen deficiency-induced osteoporosisZhaoning Li, Guixin Yuan, Xixi Lin, et al.
Journal of Cellular Physiology|December 6, 2018
Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathwaysYouqiang Sun, Yuhao Liu, Wei He, et al.
Journal of Cellular Physiology|August 28, 2020
Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-κB and MAPK pathwaysShijie Liao, Wenyu Feng, Yun Liu, et al.
The American Journal of Clinical Nutrition|June 11, 2021
An emerging role of Prevotella histicola on estrogen deficiency-induced bone loss through the gut microbiota-bone axis in postmenopausal women and in ovariectomized miceZhongxiang Wang, Kai Chen, Congcong Wu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 2025
Heme metabolism mediates RANKL-induced osteoclastogenesis via mitochondrial oxidative phosphorylationHeng Qiu, Haiming Jin, Jiansen Miao, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 13, 2023
A new insight of immunosuppressive microenvironment in osteosarcoma lung metastasisMingwei He, Xiaohong Jiang, Jifeng Miao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 7, 2025
Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone lossLiang Mo, Yuxuan Xue, Xiaohang Zheng, et al.
Journal of Cellular Physiology|December 16, 2018
Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivoFangsheng Fu, Siyuan Shao, Ziyi Wang, et al.
Arthritis and Rheumatism|January 22, 2013
Divergent effects of endogenous and exogenous glucocorticoid-induced leucine zipper in animal models of inflammation and arthritisDevi Ngo, Elaine Beaulieu, Ran Gu, et al.
Pageof 41

Showing results (321-330 of 401) with videos related to

Sort By:
Pageof 41
Frontiers in Pharmacology|March 18, 2022
Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced OsteolysisLinke Huang, Weiwei Chen, Linhua Wei, et al.
Biochemical Pharmacology|February 6, 2019
Dehydrocostus lactone (DHC) suppresses estrogen deficiency-induced osteoporosisZhaoning Li, Guixin Yuan, Xixi Lin, et al.
Journal of Cellular Physiology|December 6, 2018
Cajaninstilbene acid inhibits osteoporosis through suppressing osteoclast formation and RANKL-induced signaling pathwaysYouqiang Sun, Yuhao Liu, Wei He, et al.
Journal of Cellular Physiology|August 28, 2020
Inhibitory effects of biochanin A on titanium particle-induced osteoclast activation and inflammatory bone resorption via NF-κB and MAPK pathwaysShijie Liao, Wenyu Feng, Yun Liu, et al.
The American Journal of Clinical Nutrition|June 11, 2021
An emerging role of Prevotella histicola on estrogen deficiency-induced bone loss through the gut microbiota-bone axis in postmenopausal women and in ovariectomized miceZhongxiang Wang, Kai Chen, Congcong Wu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 12, 2025
Heme metabolism mediates RANKL-induced osteoclastogenesis via mitochondrial oxidative phosphorylationHeng Qiu, Haiming Jin, Jiansen Miao, et al.
Experimental Biology and Medicine (Maywood, N.J.)|July 13, 2023
A new insight of immunosuppressive microenvironment in osteosarcoma lung metastasisMingwei He, Xiaohong Jiang, Jifeng Miao, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 7, 2025
Bisabolangelone targets CSF1R to impede osteoclastogenesis and attenuate estrogen-deficiency bone lossLiang Mo, Yuxuan Xue, Xiaohang Zheng, et al.
Journal of Cellular Physiology|December 16, 2018
Scutellarein inhibits RANKL-induced osteoclast formation in vitro and prevents LPS-induced bone loss in vivoFangsheng Fu, Siyuan Shao, Ziyi Wang, et al.
Arthritis and Rheumatism|January 22, 2013
Divergent effects of endogenous and exogenous glucocorticoid-induced leucine zipper in animal models of inflammation and arthritisDevi Ngo, Elaine Beaulieu, Ran Gu, et al.
Pageof 41